Correlation Between Farglory FTZ and Medigen Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Farglory FTZ and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Farglory FTZ and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Farglory FTZ Investment and Medigen Biotechnology, you can compare the effects of market volatilities on Farglory FTZ and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Farglory FTZ with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Farglory FTZ and Medigen Biotechnology.

Diversification Opportunities for Farglory FTZ and Medigen Biotechnology

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Farglory and Medigen is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Farglory FTZ Investment and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and Farglory FTZ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Farglory FTZ Investment are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of Farglory FTZ i.e., Farglory FTZ and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between Farglory FTZ and Medigen Biotechnology

Assuming the 90 days trading horizon Farglory FTZ Investment is expected to generate 0.49 times more return on investment than Medigen Biotechnology. However, Farglory FTZ Investment is 2.04 times less risky than Medigen Biotechnology. It trades about 0.16 of its potential returns per unit of risk. Medigen Biotechnology is currently generating about -0.03 per unit of risk. If you would invest  4,240  in Farglory FTZ Investment on December 1, 2024 and sell it today you would earn a total of  150.00  from holding Farglory FTZ Investment or generate 3.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Farglory FTZ Investment  vs.  Medigen Biotechnology

 Performance 
       Timeline  
Farglory FTZ Investment 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Farglory FTZ Investment has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Farglory FTZ is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Medigen Biotechnology 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Medigen Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Farglory FTZ and Medigen Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Farglory FTZ and Medigen Biotechnology

The main advantage of trading using opposite Farglory FTZ and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Farglory FTZ position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.
The idea behind Farglory FTZ Investment and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity